Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity

Abstract Objective Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), cons...

Full description

Bibliographic Details
Main Authors: Hanna Lee, Young Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Mingyo Kim, Hae Sook Noh, Hyun-Ok Kim
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-022-06008-0
_version_ 1818066790906855424
author Hanna Lee
Young Sun Suh
Sang-Il Lee
Yun-Hong Cheon
Mingyo Kim
Hae Sook Noh
Hyun-Ok Kim
author_facet Hanna Lee
Young Sun Suh
Sang-Il Lee
Yun-Hong Cheon
Mingyo Kim
Hae Sook Noh
Hyun-Ok Kim
author_sort Hanna Lee
collection DOAJ
description Abstract Objective Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), consistent with our previous study. Therefore, the present study aimed to reproduce the previous results. Results The serum IGFBP-3 level was not significantly different among the three groups according to disease activity based on the DAS28-ESR/CRP (p > 0.05) but was significantly different between the low- and high-disease-activity groups based on the DAS28-CRP (p = 0.036). Meanwhile, the interleukin-6 (IL-6) level moderately correlated with DAS28-CRP (Spearman’s rho = 0.583, p < 0.001).
first_indexed 2024-12-10T15:13:23Z
format Article
id doaj.art-76718687902b432499df5ac6ad419f1e
institution Directory Open Access Journal
issn 1756-0500
language English
last_indexed 2024-12-10T15:13:23Z
publishDate 2022-04-01
publisher BMC
record_format Article
series BMC Research Notes
spelling doaj.art-76718687902b432499df5ac6ad419f1e2022-12-22T01:43:52ZengBMCBMC Research Notes1756-05002022-04-011511510.1186/s13104-022-06008-0Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activityHanna Lee0Young Sun Suh1Sang-Il Lee2Yun-Hong Cheon3Mingyo Kim4Hae Sook Noh5Hyun-Ok Kim6Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and Changwon HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and Institute of Health Science, Gyeongsang National University HospitalDivision of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine and Changwon HospitalAbstract Objective Insulin-like growth factor (IGF)-1 participates in modulating immunity and inflammation. Its bioactivity is controlled by six IGF-binding proteins (IGFBP-1 to IGFBP-6). In particular, the IGFBP-3 level is reportedly linked to the disease activity of rheumatoid arthritis (RA), consistent with our previous study. Therefore, the present study aimed to reproduce the previous results. Results The serum IGFBP-3 level was not significantly different among the three groups according to disease activity based on the DAS28-ESR/CRP (p > 0.05) but was significantly different between the low- and high-disease-activity groups based on the DAS28-CRP (p = 0.036). Meanwhile, the interleukin-6 (IL-6) level moderately correlated with DAS28-CRP (Spearman’s rho = 0.583, p < 0.001).https://doi.org/10.1186/s13104-022-06008-0Rheumatoid arthritisDisease activityInsulin-like growth factor-1Insulin-like growth factor binding protein-3
spellingShingle Hanna Lee
Young Sun Suh
Sang-Il Lee
Yun-Hong Cheon
Mingyo Kim
Hae Sook Noh
Hyun-Ok Kim
Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
BMC Research Notes
Rheumatoid arthritis
Disease activity
Insulin-like growth factor-1
Insulin-like growth factor binding protein-3
title Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
title_full Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
title_fullStr Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
title_full_unstemmed Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
title_short Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
title_sort serum igf 1 in patients with rheumatoid arthritis correlation with disease activity
topic Rheumatoid arthritis
Disease activity
Insulin-like growth factor-1
Insulin-like growth factor binding protein-3
url https://doi.org/10.1186/s13104-022-06008-0
work_keys_str_mv AT hannalee serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT youngsunsuh serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT sangillee serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT yunhongcheon serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT mingyokim serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT haesooknoh serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity
AT hyunokkim serumigf1inpatientswithrheumatoidarthritiscorrelationwithdiseaseactivity